GLP1R and atrial fibrillation: Indeed, SGLT2-i and GLP-1 RA can target both left atrial and coronary EAT for the treatment and prevention of atrial fibrillation and coronary artery disease by reducing EAT inflammation and increasing free fatty acid oxidation [13].